unomedical limited
unomedical limited Company Information
Company Number
00976940
Next Accounts
Sep 2025
Shareholders
unomedical holdings ltd
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
gdc first avenue, deeside industrial park, deeside, flintshire, CH5 2NU
Website
www.unomedical.comunomedical limited Estimated Valuation
Pomanda estimates the enterprise value of UNOMEDICAL LIMITED at £1.3m based on a Turnover of £3.6m and 0.37x industry multiple (adjusted for size and gross margin).
unomedical limited Estimated Valuation
Pomanda estimates the enterprise value of UNOMEDICAL LIMITED at £285.5k based on an EBITDA of £76k and a 3.76x industry multiple (adjusted for size and gross margin).
unomedical limited Estimated Valuation
Pomanda estimates the enterprise value of UNOMEDICAL LIMITED at £36.2m based on Net Assets of £18.9m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Unomedical Limited Overview
Unomedical Limited is a live company located in deeside, CH5 2NU with a Companies House number of 00976940. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 1970, it's largest shareholder is unomedical holdings ltd with a 100% stake. Unomedical Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.6m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Unomedical Limited Health Check
Pomanda's financial health check has awarded Unomedical Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £3.6m, make it smaller than the average company (£24.5m)
£3.6m - Unomedical Limited
£24.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -35%, show it is growing at a slower rate (5.3%)
-35% - Unomedical Limited
5.3% - Industry AVG
Production
with a gross margin of 16.3%, this company has a higher cost of product (29.4%)
16.3% - Unomedical Limited
29.4% - Industry AVG
Profitability
an operating margin of 2.1% make it less profitable than the average company (4.1%)
2.1% - Unomedical Limited
4.1% - Industry AVG
Employees
with 6 employees, this is below the industry average (36)
- Unomedical Limited
36 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Unomedical Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £601.7k, this is equally as efficient (£656k)
- Unomedical Limited
£656k - Industry AVG
Debtor Days
it gets paid by customers after 45 days, this is earlier than average (58 days)
45 days - Unomedical Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (29 days)
2 days - Unomedical Limited
29 days - Industry AVG
Stock Days
it holds stock equivalent to 49 days, this is less than average (64 days)
49 days - Unomedical Limited
64 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Unomedical Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4.9%, this is a lower level of debt than the average (54.7%)
4.9% - Unomedical Limited
54.7% - Industry AVG
UNOMEDICAL LIMITED financials
Unomedical Limited's latest turnover from December 2023 is £3.6 million and the company has net assets of £18.9 million. According to their latest financial statements, we estimate that Unomedical Limited has 6 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,610,000 | 11,870,000 | 2,752,000 | 13,440,000 | 13,562,000 | 12,882,000 | 13,792,000 | 15,183,000 | 13,962,000 | 14,103,000 | 15,570,000 | 17,674,000 | 20,908,000 | 20,467,000 | 22,343,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 3,023,000 | 8,835,000 | 1,341,000 | 9,675,000 | 10,737,000 | 9,947,000 | 10,328,000 | 11,978,000 | 10,130,000 | 8,871,000 | 10,846,000 | 14,005,000 | 17,077,000 | 18,741,000 | 19,608,000 |
| Gross Profit | 587,000 | 3,035,000 | 1,411,000 | 3,765,000 | 2,825,000 | 2,935,000 | 3,464,000 | 3,205,000 | 3,832,000 | 5,232,000 | 4,724,000 | 3,669,000 | 3,831,000 | 1,726,000 | 2,735,000 |
| Admin Expenses | 511,000 | 1,768,000 | 855,000 | 2,358,000 | 2,331,000 | 2,418,000 | 3,141,000 | 2,826,000 | 2,704,000 | 2,734,000 | 2,174,000 | 4,433,000 | 6,019,000 | 4,807,000 | 15,284,000 |
| Operating Profit | 76,000 | 1,267,000 | 556,000 | 1,407,000 | 494,000 | 517,000 | 323,000 | 379,000 | 1,128,000 | 2,498,000 | 2,550,000 | -764,000 | -2,188,000 | -3,081,000 | -12,549,000 |
| Interest Payable | 16,000 | 11,000 | 398,000 | 629,000 | 585,000 | ||||||||||
| Interest Receivable | 770,000 | 219,000 | 22,000 | 291,000 | 248,000 | 182,000 | 169,000 | 299,000 | 364,000 | 236,000 | 322,000 | 194,000 | 220,000 | 301,000 | |
| Pre-Tax Profit | 846,000 | 1,486,000 | 210,000 | 1,698,000 | 742,000 | 699,000 | 492,000 | 678,000 | 1,492,000 | 2,734,000 | 3,084,000 | -1,194,000 | 223,000 | -3,979,000 | -1,400,000 |
| Tax | -199,000 | -282,000 | -218,000 | -279,000 | -146,000 | -134,000 | -98,000 | -139,000 | -69,000 | -845,000 | 252,000 | -1,523,000 | -301,000 | ||
| Profit After Tax | 647,000 | 1,204,000 | -8,000 | 1,419,000 | 596,000 | 565,000 | 394,000 | 539,000 | 1,423,000 | 1,889,000 | 3,336,000 | -1,194,000 | -1,300,000 | -3,979,000 | -1,701,000 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 647,000 | 1,204,000 | -8,000 | 1,419,000 | 596,000 | 565,000 | 394,000 | 539,000 | 1,423,000 | 1,889,000 | 3,336,000 | -1,194,000 | -1,300,000 | -3,979,000 | -1,701,000 |
| Employee Costs | 576,000 | 1,701,000 | 1,943,000 | 3,440,000 | |||||||||||
| Number Of Employees | 22 | 67 | 75 | 129 | |||||||||||
| EBITDA* | 76,000 | 1,267,000 | 556,000 | 1,407,000 | 494,000 | 517,000 | 323,000 | 379,000 | 1,128,000 | 2,498,000 | 2,564,000 | -652,000 | -2,035,000 | -2,934,000 | -11,490,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,284,000 | 1,584,000 | 1,705,000 | 1,832,000 | |||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 27,470,000 | 27,470,000 | |||||||||||||
| Debtors (Due After 1 year) | 24,000 | 24,000 | 25,000 | ||||||||||||
| Total Fixed Assets | 24,000 | 24,000 | 25,000 | 1,284,000 | 1,584,000 | 29,175,000 | 29,302,000 | ||||||||
| Stock & work in progress | 407,000 | 472,000 | 1,643,000 | 2,027,000 | 2,591,000 | 1,399,000 | 2,516,000 | 2,565,000 | 2,050,000 | 1,881,000 | 1,804,000 | 2,419,000 | 4,271,000 | 4,616,000 | 4,005,000 |
| Trade Debtors | 448,000 | 1,441,000 | 1,523,000 | 1,616,000 | 1,605,000 | 1,884,000 | 1,679,000 | 1,883,000 | 1,867,000 | 2,233,000 | 1,979,000 | 2,194,000 | 3,406,000 | 3,660,000 | 5,155,000 |
| Group Debtors | 18,861,000 | 17,890,000 | 16,017,000 | 13,617,000 | 9,453,000 | 8,586,000 | 5,730,000 | 5,827,000 | 7,781,000 | 8,118,000 | 337,000 | 434,000 | 8,276,000 | 8,230,000 | 6,504,000 |
| Misc Debtors | 108,000 | 119,000 | 108,000 | 23,000 | 26,000 | 36,000 | 121,000 | 69,000 | 319,000 | 513,000 | 634,000 | 1,065,000 | 51,000 | 1,635,000 | 1,514,000 |
| Cash | 1,634,000 | 2,589,000 | 1,756,000 | 3,633,000 | 2,649,000 | 1,086,000 | 1,916,000 | 7,168,000 | 3,443,000 | 2,180,000 | 558,000 | 1,487,000 | |||
| misc current assets | |||||||||||||||
| total current assets | 19,824,000 | 19,922,000 | 19,291,000 | 18,917,000 | 16,264,000 | 13,661,000 | 13,679,000 | 12,993,000 | 13,103,000 | 14,661,000 | 11,922,000 | 9,555,000 | 18,184,000 | 18,699,000 | 18,665,000 |
| total assets | 19,848,000 | 19,946,000 | 19,316,000 | 18,917,000 | 16,264,000 | 13,661,000 | 13,679,000 | 12,993,000 | 13,103,000 | 14,661,000 | 11,922,000 | 10,839,000 | 19,768,000 | 47,874,000 | 47,967,000 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 23,000 | 90,000 | 134,000 | 20,000 | 24,000 | 76,000 | 21,000 | 48,000 | 80,000 | 310,000 | 275,000 | 330,000 | 674,000 | 739,000 | 2,066,000 |
| Group/Directors Accounts | 772,000 | 1,317,000 | 1,399,000 | 1,955,000 | 2,505,000 | 707,000 | 1,571,000 | 1,042,000 | 1,081,000 | 3,944,000 | 1,983,000 | 2,730,000 | 9,139,000 | 6,046,000 | 609,000 |
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 186,000 | 319,000 | 767,000 | 1,079,000 | 925,000 | 664,000 | 438,000 | 648,000 | 1,226,000 | 737,000 | 798,000 | 644,000 | 721,000 | 332,000 | 1,054,000 |
| total current liabilities | 981,000 | 1,726,000 | 2,300,000 | 3,054,000 | 3,454,000 | 1,447,000 | 2,030,000 | 1,738,000 | 2,387,000 | 4,991,000 | 3,056,000 | 3,704,000 | 10,534,000 | 7,117,000 | 3,729,000 |
| loans | 304,000 | 40,623,000 | 40,023,000 | ||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 411,000 | 1,009,000 | 41,085,000 | 41,049,000 | |||||||||||
| total liabilities | 981,000 | 1,726,000 | 2,300,000 | 3,054,000 | 3,454,000 | 1,447,000 | 2,030,000 | 1,738,000 | 2,387,000 | 4,991,000 | 3,056,000 | 4,115,000 | 11,543,000 | 48,202,000 | 44,778,000 |
| net assets | 18,867,000 | 18,220,000 | 17,016,000 | 15,863,000 | 12,810,000 | 12,214,000 | 11,649,000 | 11,255,000 | 10,716,000 | 9,670,000 | 8,866,000 | 6,724,000 | 8,225,000 | -328,000 | 3,189,000 |
| total shareholders funds | 18,867,000 | 18,220,000 | 17,016,000 | 15,863,000 | 12,810,000 | 12,214,000 | 11,649,000 | 11,255,000 | 10,716,000 | 9,670,000 | 8,866,000 | 6,724,000 | 8,225,000 | -328,000 | 3,189,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 76,000 | 1,267,000 | 556,000 | 1,407,000 | 494,000 | 517,000 | 323,000 | 379,000 | 1,128,000 | 2,498,000 | 2,550,000 | -764,000 | -2,188,000 | -3,081,000 | -12,549,000 |
| Depreciation | 14,000 | 112,000 | 153,000 | 147,000 | 173,000 | ||||||||||
| Amortisation | 886,000 | ||||||||||||||
| Tax | -199,000 | -282,000 | -218,000 | -279,000 | -146,000 | -134,000 | -98,000 | -139,000 | -69,000 | -845,000 | 252,000 | -1,523,000 | -301,000 | ||
| Stock | -65,000 | -1,171,000 | -384,000 | -564,000 | 1,192,000 | -1,117,000 | -49,000 | 515,000 | 169,000 | 77,000 | -615,000 | -1,852,000 | -345,000 | 611,000 | 4,005,000 |
| Debtors | -33,000 | 1,801,000 | 2,417,000 | 4,172,000 | 578,000 | 2,976,000 | -249,000 | -2,188,000 | -897,000 | 7,914,000 | -743,000 | -8,040,000 | -1,792,000 | 352,000 | 13,173,000 |
| Creditors | -67,000 | -44,000 | 114,000 | -4,000 | -52,000 | 55,000 | -27,000 | -32,000 | -230,000 | 35,000 | -55,000 | -344,000 | -65,000 | -1,327,000 | 2,066,000 |
| Accruals and Deferred Income | -133,000 | -448,000 | -312,000 | 154,000 | 261,000 | 226,000 | -210,000 | -578,000 | 489,000 | -61,000 | 154,000 | -77,000 | 389,000 | -722,000 | 1,054,000 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -225,000 | -137,000 | -1,893,000 | -2,330,000 | -1,213,000 | -1,195,000 | 286,000 | 1,303,000 | 2,046,000 | -6,364,000 | 4,273,000 | 8,819,000 | -1,097,000 | -5,946,000 | -25,849,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -27,470,000 | 27,470,000 | |||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -545,000 | -82,000 | -556,000 | -550,000 | 1,798,000 | -864,000 | 529,000 | -39,000 | -2,863,000 | 1,961,000 | -747,000 | -6,409,000 | 3,093,000 | 5,437,000 | 609,000 |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -304,000 | -40,319,000 | 600,000 | 40,023,000 | |||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 770,000 | 219,000 | 22,000 | 291,000 | 248,000 | 182,000 | 169,000 | 299,000 | 364,000 | 236,000 | -16,000 | 311,000 | -204,000 | -409,000 | -284,000 |
| cash flow from financing | 225,000 | 137,000 | 627,000 | 1,375,000 | 2,046,000 | -682,000 | 698,000 | 260,000 | -2,876,000 | 1,112,000 | -1,957,000 | -6,709,000 | -27,577,000 | 6,090,000 | 45,238,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -1,634,000 | -955,000 | 833,000 | -1,877,000 | 984,000 | 1,563,000 | -830,000 | -5,252,000 | 3,725,000 | 1,263,000 | 1,622,000 | -929,000 | 1,487,000 | ||
| overdraft | |||||||||||||||
| change in cash | -1,634,000 | -955,000 | 833,000 | -1,877,000 | 984,000 | 1,563,000 | -830,000 | -5,252,000 | 3,725,000 | 1,263,000 | 1,622,000 | -929,000 | 1,487,000 |
unomedical limited Credit Report and Business Information
Unomedical Limited Competitor Analysis
Perform a competitor analysis for unomedical limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in CH5 area or any other competitors across 12 key performance metrics.
unomedical limited Ownership
UNOMEDICAL LIMITED group structure
Unomedical Limited has 2 subsidiary companies.
Ultimate parent company
2 parents
UNOMEDICAL LIMITED
00976940
2 subsidiaries
unomedical limited directors
Unomedical Limited currently has 2 directors. The longest serving directors include Mrs. Fiona Ryder (Mar 2022) and Mr Stephen Howe (May 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs. Fiona Ryder | 50 years | Mar 2022 | - | Director | |
| Mr Stephen Howe | United Kingdom | 51 years | May 2024 | - | Director |
P&L
December 2023turnover
3.6m
-70%
operating profit
76k
-94%
gross margin
16.3%
-36.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
18.9m
+0.04%
total assets
19.8m
0%
cash
0
0%
net assets
Total assets minus all liabilities
unomedical limited company details
company number
00976940
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 1970
age
55
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
maersk medical limited (May 2003)
maersk medical developments limited (January 2000)
See moreaccountant
-
auditor
DELOITTE LLP
address
gdc first avenue, deeside industrial park, deeside, flintshire, CH5 2NU
Bank
NORDEA BANK
Legal Advisor
-
unomedical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to unomedical limited. Currently there are 0 open charges and 10 have been satisfied in the past.
unomedical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for UNOMEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
unomedical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
